Thank you for your interest in participating in HealthTech Capital’s Analyst-in-Residence program (AiR).
Due to SEC requirements to maintain private fundraising pitches, all of our meetings are confidential. Before you can join our first meeting, you must sign an NDA (non-disclosure agreement). All related information exchanged inside or outside meetings would also be confidential.
The AiR program is an educational program for upcoming professional s post graduate school. You can volunteer your time to help with the operations of HTC in exchange for invaluable resources - we offer an opportunity to learn about early stage investing, due diligence, and portfolio management. In addition, you’ll have access to our network of members who have a broad range of expertise. Your experience and learning will depend on how much time and energy you are willing to invest in HTC.
HTC pre-screens applicant companies through a monthly screening call with members and AiRs. Prior to the pre-screening call, we (AiRs and members) review and rate the companies using a platform called Proseeder. As an outcome of the pre-screening calls, HTC invites 4 companies to a monthly screening dinner meeting which is usually held on the 3rd Tuesday of every month in Palo Alto. During the screening meetings, the participants and members vote to select companies we would like to enter due diligence (DD) with. A DD team is formed (composed of members and AIRs) which follows up with the company, performs due diligence, summarize their findings in a DD report and shares their findings at the next HTC meeting.
Here is how you can participate based on different events: